Compare Dorman Products, Inc. with Similar Stocks
Dashboard
High Management Efficiency with a high ROCE of 16.25%
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.37 times
Healthy long term growth as Net Sales has grown by an annual rate of 16.21%
The company has declared Positive results for the last 5 consecutive quarters
With ROCE of 19.46%, it has a expensive valuation with a 2.45 Enterprise value to Capital Employed
Stock DNA
Auto Components & Equipments
USD 3,914 Million (Small Cap)
17.00
NA
0.00%
0.27
16.75%
2.64
Total Returns (Price + Dividend) 
Dorman Products, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

Dorman Products Adjusts Valuation Amid Strong Financial Performance and Growth Potential
Dorman Products, Inc. has recently experienced a change in its evaluation score, linked to a shift in its valuation grade. The company showcases strong financial metrics, including a solid return on capital and equity, low debt levels, and consistent sales growth, indicating robust financial health and investor confidence.
Read full news article Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 86 Schemes (46.1%)
Held by 115 Foreign Institutions (7.08%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
YoY Growth in quarter ended Jun 2025 is 7.55% vs 4.66% in Jun 2024
YoY Growth in quarter ended Jun 2025 is 23.84% vs 44.51% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 4.11% vs 11.31% in Dec 2023
YoY Growth in year ended Dec 2024 is 46.95% vs 6.42% in Dec 2023






